IGM Biosciences (STU:1K0) EV-to-Revenue : 139.52 (As of May. 17, 2024)

View and export this data going back to 2019. Start your Free Trial

What is IGM Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, IGM Biosciences's enterprise value is €271.36 Mil. IGM Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €1.95 Mil. Therefore, IGM Biosciences's EV-to-Revenue for today is 139.52.

The historical rank and industry rank for IGM Biosciences's EV-to-Revenue or its related term are showing as below:

STU:1K0' s EV-to-Revenue Range Over the Past 10 Years
Min: -54.2 Med: 159.76 Max: 1882.5
Current: 140.37

During the past 7 years, the highest EV-to-Revenue of IGM Biosciences was 1882.50. The lowest was -54.20. And the median was 159.76.

STU:1K0's EV-to-Revenue is ranked worse than
86.39% of 1043 companies
in the Biotechnology industry
Industry Median: 8.03 vs STU:1K0: 140.37

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), IGM Biosciences's stock price is €8.60. IGM Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.04. Therefore, IGM Biosciences's PS Ratio for today is 245.71.

IGM Biosciences EV-to-Revenue Historical Data

The historical data trend for IGM Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGM Biosciences EV-to-Revenue Chart

IGM Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

324.45

89.42

IGM Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															164.24	84.48	76.56	89.42	150.14

Competitive Comparison of IGM Biosciences's EV-to-Revenue

For the Biotechnology subindustry, IGM Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IGM Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IGM Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where IGM Biosciences's EV-to-Revenue falls into.

IGM Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

IGM Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	271.362	/	1.945
	=	139.52

IGM Biosciences's current Enterprise Value is €271.36 Mil.
IGM Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.95 Mil.

IGM Biosciences (STU:1K0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

IGM Biosciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	8.60	/	0.035
	=	245.71

IGM Biosciences's share price for today is €8.60.
IGM Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04.

IGM Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of IGM Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

IGM Biosciences (STU:1K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGM Biosciences Inc (STU:1K0) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

IGMS:USA

Address

325 East Middlefield Road, Mountain View, CA, USA, 94043

Website

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

IGM Biosciences (STU:1K0) Headlines

No Headlines